Dated disclosed rounds · latest 2025-04-02
Later stage / growth
CMR Surgical
Surgical robotics; Surgical robotics (medtech)
VerifiedSeries FCambridge
- Companies House
- 08863657
- GLEIF LEI
- Not matched
- Latest evidence
- 2025-04-02
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-01
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
4 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
FundingSource fact Series F
$200M (Series F, 2025); $600M (Series D, 2021) · 8 named investors
FundingSource fact Series D
$600m (2021 Series D); $165m (2023 follow-on, existing investors only) · 9 named investors
RegistryRegistry fact Company incorporated
CMR SURGICAL LIMITED · company 08863657
Latest disclosed round
Series F
- Date
- 2025-04-02
- Amount
- USD 200m
- Sector
- Deeptech / hardware; Healthtech & digital health
- Companies House
- 08863657
- ONS region
- East
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
12 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
SoftBank Vision Fund 2leadAlly Bridge GroupparticipantCambridge Innovation CapitalparticipantEscala CapitalparticipantGE HealthcareparticipantLGTparticipantLGT/LightrockparticipantLightrockparticipantRPMI RailpenparticipantTencentparticipantTrinity CapitalparticipantWatriumparticipant
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| SoftBank Vision Fund 2 | lead | 2025-04-02 | Sifted ↗ · Fiercebiotech ↗ · Cambridgenetwork ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Ally Bridge Group | participant | 2025-04-02 | Sifted ↗ · Fiercebiotech ↗ · Cambridgenetwork ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Cambridge Innovation Capital | participant | 2025-04-02 | Sifted ↗ · Fiercebiotech ↗ · Cambridgenetwork ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Escala Capital | participant | 2023-10-01 | Sifted ↗ · Fiercebiotech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| GE Healthcare | participant | 2025-04-02 | Cambridgenetwork ↗ · Ally Bridge ↗ · Tracxn ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| LGT | participant | 2023-10-01 | Sifted ↗ · Fiercebiotech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| LGT/Lightrock | participant | 2025-04-02 | Cambridgenetwork ↗ · Ally Bridge ↗ · Tracxn ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Lightrock | participant | 2023-10-01 | Sifted ↗ · Fiercebiotech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| RPMI Railpen | participant | 2025-04-02 | Sifted ↗ · Fiercebiotech ↗ · Cambridgenetwork ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Tencent | participant | 2025-04-02 | Sifted ↗ · Fiercebiotech ↗ · Cambridgenetwork ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Trinity Capital | participant | 2025-04-02 | Cambridgenetwork ↗ · Ally Bridge ↗ · Tracxn ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Watrium | participant | 2023-10-01 | Sifted ↗ · Fiercebiotech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
2 disclosed rounds
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2025-04-02 | Series F | $200M (Series F, 2025); $600M (Series D, 2021) | Ally Bridge Group · Tencent · RPMI Railpen · LGT/Lightrock · Cambridge Innovation Capital · GE Healthcare · 2 additional source-listed names | Cambridgenetwork ↗ · Ally Bridge ↗ · Tracxn ↗ |
| 2023-10-01 | Series D | $600m (2021 Series D); $165m (2023 follow-on, existing investors only) | SoftBank Vision Fund 2 · Ally Bridge Group · Cambridge Innovation Capital · Escala Capital · LGT · Lightrock · + 3 more linked | Sifted ↗ · Fiercebiotech ↗ |
Companies House status and filing snapshot
CMR SURGICAL LIMITED
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2014-01-27
- Dissolved
- Not applicable
- Company number
- 08863657
Filing context
- Accounts category
- GROUP
- Accounts made up to
- 2024-12-31
- Next accounts due
- 2026-09-30
- Confirmation made up to
- 2026-01-03
- Registry snapshot
- 2026-08-01
- Live check
- Bulk snapshot only
Former registered names: CAMBRIDGE MEDICAL ROBOTICS LIMITED
32500Manufacture of medical and dental instruments and supplies72190Other research and experimental development on natural sciences and engineering
Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.